TRIMTECH Therapeutics
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
$47MSeed+
Role not disclosedLoading investors…
Activity from announced rounds
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
Provides real-time analytics, data warehousing, observability, and AI/ML infrastructure
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
Pitching Inc.? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room